JP2022533981A5 - - Google Patents
Info
- Publication number
- JP2022533981A5 JP2022533981A5 JP2021568760A JP2021568760A JP2022533981A5 JP 2022533981 A5 JP2022533981 A5 JP 2022533981A5 JP 2021568760 A JP2021568760 A JP 2021568760A JP 2021568760 A JP2021568760 A JP 2021568760A JP 2022533981 A5 JP2022533981 A5 JP 2022533981A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- compound
- formula
- approximately
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024139784A JP2024178168A (ja) | 2019-05-23 | 2024-08-21 | ブルトン型チロシンキナーゼ阻害薬を用いて慢性自発性蕁麻疹を治療する方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962851996P | 2019-05-23 | 2019-05-23 | |
| US62/851,996 | 2019-05-23 | ||
| PCT/IB2020/054755 WO2020234782A1 (en) | 2019-05-23 | 2020-05-20 | Methods of treating chronic spontaneous urticaria using a bruton's tyrosine kinase inhibitor |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024139784A Division JP2024178168A (ja) | 2019-05-23 | 2024-08-21 | ブルトン型チロシンキナーゼ阻害薬を用いて慢性自発性蕁麻疹を治療する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022533981A JP2022533981A (ja) | 2022-07-27 |
| JP2022533981A5 true JP2022533981A5 (https=) | 2023-05-26 |
| JP7568651B2 JP7568651B2 (ja) | 2024-10-16 |
Family
ID=70918751
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021568760A Active JP7568651B2 (ja) | 2019-05-23 | 2020-05-20 | ブルトン型チロシンキナーゼ阻害薬を用いて慢性自発性蕁麻疹を治療する方法 |
| JP2024139784A Pending JP2024178168A (ja) | 2019-05-23 | 2024-08-21 | ブルトン型チロシンキナーゼ阻害薬を用いて慢性自発性蕁麻疹を治療する方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024139784A Pending JP2024178168A (ja) | 2019-05-23 | 2024-08-21 | ブルトン型チロシンキナーゼ阻害薬を用いて慢性自発性蕁麻疹を治療する方法 |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US12419889B2 (https=) |
| EP (2) | EP4599894A3 (https=) |
| JP (2) | JP7568651B2 (https=) |
| KR (1) | KR20220012281A (https=) |
| CN (1) | CN113795255A (https=) |
| AU (2) | AU2020280272B2 (https=) |
| BR (1) | BR112021022602A2 (https=) |
| CA (1) | CA3138081A1 (https=) |
| CL (1) | CL2021003032A1 (https=) |
| DK (1) | DK3972604T3 (https=) |
| ES (1) | ES3039974T3 (https=) |
| FI (1) | FI3972604T3 (https=) |
| HR (1) | HRP20251001T1 (https=) |
| IL (1) | IL286983B2 (https=) |
| LT (1) | LT3972604T (https=) |
| MX (2) | MX2021013942A (https=) |
| PL (1) | PL3972604T3 (https=) |
| PT (1) | PT3972604T (https=) |
| RS (1) | RS67141B1 (https=) |
| SI (1) | SI3972604T1 (https=) |
| TW (2) | TW202537625A (https=) |
| WO (1) | WO2020234782A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS67141B1 (sr) | 2019-05-23 | 2025-09-30 | Novartis Ag | Inhibitor brutonove tirozin kinaze za upotrebu u lečenju hronične spontane urtikarije |
| JP7564347B2 (ja) | 2021-09-03 | 2024-10-08 | ノバルティス アーゲー | 多発性硬化症を治療するためのｌｏｕ０６４ |
| US20250032488A1 (en) | 2021-12-14 | 2025-01-30 | Novartis Ag | Methods of treatment using lou064 |
| TW202342048A (zh) | 2022-02-28 | 2023-11-01 | 瑞士商諾華公司 | 使用ｌｏｕ０６４治療化膿性汗腺炎之方法 |
| KR102834740B1 (ko) * | 2023-04-10 | 2025-07-17 | 아주대학교산학협력단 | Hsp10 또는 이의 항체를 유효성분으로 포함하는 만성 자발적 두드러기의 진단을 위한 바이오마커 조성물 |
| WO2024235163A1 (zh) * | 2023-05-12 | 2024-11-21 | 武汉人福创新药物研发中心有限公司 | Btk抑制剂的用途和单剂量药物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2705719C (en) | 2007-09-14 | 2016-10-11 | Janssen Pharmaceutica N.V. | Thieno-and furo-pyrimidine modulators of the histamine h4 receptor |
| US9512084B2 (en) * | 2013-11-29 | 2016-12-06 | Novartis Ag | Amino pyrimidine derivatives |
| EP3092250A4 (en) | 2014-01-08 | 2017-05-24 | Moderna Therapeutics, Inc. | Polynucleotides for the in vivo production of antibodies |
| WO2016079669A1 (en) * | 2014-11-19 | 2016-05-26 | Novartis Ag | Labeled amino pyrimidine derivatives |
| RS67141B1 (sr) | 2019-05-23 | 2025-09-30 | Novartis Ag | Inhibitor brutonove tirozin kinaze za upotrebu u lečenju hronične spontane urtikarije |
-
2020
- 2020-05-20 RS RS20250816A patent/RS67141B1/sr unknown
- 2020-05-20 AU AU2020280272A patent/AU2020280272B2/en active Active
- 2020-05-20 US US17/612,778 patent/US12419889B2/en active Active
- 2020-05-20 CA CA3138081A patent/CA3138081A1/en active Pending
- 2020-05-20 BR BR112021022602A patent/BR112021022602A2/pt unknown
- 2020-05-20 HR HRP20251001TT patent/HRP20251001T1/hr unknown
- 2020-05-20 LT LTEPPCT/IB2020/054755T patent/LT3972604T/lt unknown
- 2020-05-20 EP EP25178785.9A patent/EP4599894A3/en active Pending
- 2020-05-20 ES ES20729204T patent/ES3039974T3/es active Active
- 2020-05-20 SI SI202030651T patent/SI3972604T1/sl unknown
- 2020-05-20 MX MX2021013942A patent/MX2021013942A/es unknown
- 2020-05-20 PL PL20729204.6T patent/PL3972604T3/pl unknown
- 2020-05-20 JP JP2021568760A patent/JP7568651B2/ja active Active
- 2020-05-20 CN CN202080032000.3A patent/CN113795255A/zh active Pending
- 2020-05-20 IL IL286983A patent/IL286983B2/en unknown
- 2020-05-20 PT PT207292046T patent/PT3972604T/pt unknown
- 2020-05-20 KR KR1020217041089A patent/KR20220012281A/ko not_active Ceased
- 2020-05-20 DK DK20729204.6T patent/DK3972604T3/da active
- 2020-05-20 WO PCT/IB2020/054755 patent/WO2020234782A1/en not_active Ceased
- 2020-05-20 FI FIEP20729204.6T patent/FI3972604T3/fi active
- 2020-05-20 EP EP20729204.6A patent/EP3972604B1/en active Active
- 2020-05-21 TW TW113146310A patent/TW202537625A/zh unknown
- 2020-05-21 TW TW109116854A patent/TWI868139B/zh active
-
2021
- 2021-11-12 MX MX2024014626A patent/MX2024014626A/es unknown
- 2021-11-17 CL CL2021003032A patent/CL2021003032A1/es unknown
-
2024
- 2024-08-21 JP JP2024139784A patent/JP2024178168A/ja active Pending
-
2025
- 2025-08-27 US US19/311,292 patent/US20250375446A1/en active Pending
- 2025-10-17 AU AU2025252618A patent/AU2025252618A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022533981A5 (https=) | ||
| EP1377278B1 (en) | Treatment of type 2 diabetes with inhibitors of dipeptidyl peptidase iv | |
| JP2001509173A (ja) | 胃腸リパーゼ阻害剤の使用 | |
| EP4322942B1 (en) | Combination comprising everolimus and amcenestrant | |
| JP2004518653A (ja) | 不安障害を治療する方法 | |
| TW202011965A (zh) | 嗜中性球彈性蛋白酶抑制劑在肝病中之用途 | |
| WO2019046287A1 (en) | COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING HEPATITIS B | |
| EP0708644A4 (en) | TREATMENT OF -i INFECTION (CRYPTOCOCCUS NEOFORMANS) | |
| WO2004067006A1 (en) | Combination of a pde iv inhibitor and a tnf-alpha antagonist | |
| EP2808018B1 (en) | Therapeutic agent for diabetes | |
| EP3132803B1 (en) | Preventive or therapeutic agent for pain associated with herpes zoster in acute phase | |
| CN1203861C (zh) | 含有人参皂甙Rb1的脑血管再生/再造促进剂和继发性神经组织变性抑制剂 | |
| JP4609877B2 (ja) | 慢性拒絶反応抑制剤 | |
| US6090775A (en) | Treatment of neurological conditions by an interleukin-1 inhibiting compound | |
| TW202116297A (zh) | 組合療法之方法、組成物與套組 | |
| CA2241856C (en) | Agent for prophylaxis and treatment of diabetic complications | |
| TWI411435B (zh) | ４－環丙基甲氧基－ｎ－（３，５－二氯－１－氧離子基吡啶－４－基）－５－（甲氧基）吡啶－２－甲醯胺於治療脊髓創傷之用途 | |
| US20060135494A1 (en) | Methods of treating injuries of the nervous system associated with hemorrhage | |
| JP2003522121A (ja) | 多発性硬化症の処置のためのリルゾールの使用 | |
| WO2023203022A1 (en) | Treatment of neutrophilic dermatoses | |
| US9248118B2 (en) | Compositions and method for treatment of ischemic neuronal reperfusion injury | |
| EP3558378A1 (en) | Low dose drug combinations for use in preventing and treating neuronal damage | |
| RU2721282C2 (ru) | Способ лечения рассеянного склероза (варианты) | |
| CA2684171C (fr) | Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxydo-4-pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des traumatismes craniens | |
| CN1108532A (zh) | 皮肤癌治疗 |